Schreiber R, Crane K, Patel J. Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials. J of Skin [Internet]. 2017 Oct. 27 [cited 2024 Jul. 3];1(3.1):s50. Available from: https://jofskin.org/33014/index.php/skin/article/view/176